Cell analysis solutions company Cytek Biosciences, Inc. (CTKB) announced Thursday that its Board of Directors has approved the repurchase of up to an aggregate of $50 million of its common stock, subject to compliance with applicable law.
The Company's common stock is listed on The Nasdaq Global Select Market under the symbol "CTKB". The repurchase program will continue until December 31, 2024 unless extended or shortened by the Board of Directors.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.